EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Europa Uomo Patient Reported Outcome Study 2.0—Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-making

Lionne D F Venderbos, Sebastiaan Remmers, André Deschamps, John Dowling, Ernst-Günter Carl, Nuno Pereira-Azevedo, Monique J Roobol

European Urology Focus · 2023-11 · 9 (6) · 1024-1036

DOI: 10.1016/j.euf.2023.05.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Urology Focus, 2023-11. Verfasst von Lionne D F Venderbos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: l.venderbos@er…. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Prostatic Neoplasms, Urinary Incontinence. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis Pharmaceuticals Corporation, Janssen LP, Astellas Pharma Netherlands.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Initiation and Maintenance DisordersProstatic NeoplasmsUrinary IncontinenceMaleHumansProstate-Specific AntigenQuality of LifeCross-Sectional StudiesPatient Reported Outcome Measures

Stichwörter der Autor:innen

EORTC-QLQ-C30EPIC-26EQ-5D-5LPatient engagementPatient organizationPatient voiceProstate cancerSDM-Q-9

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: l.venderbos@erasmusmc.nl.
  • Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Europa Uomo, Antwerp, Belgium.
  • Department of Urology, Entre o Douro e Vouga Medical Center, Santa Maria da Feira, Portugal.

Förderung

  • Novartis Pharmaceuticals Corporation
  • Janssen LP
  • Astellas Pharma Netherlands
  • Ipsen Pharma SA
  • AstraZeneca Canada Inc

Zitieren

APA

Venderbos, L. D. F., Remmers, S., Deschamps, A., Dowling, J., Carl, E. G., Pereira-Azevedo, N., & Roobol, M. J. (2023). The Europa Uomo Patient Reported Outcome Study 2.0—Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-making. European Urology Focus, 9(6), 1024-1036. https://doi.org/10.1016/j.euf.2023.05.006

Vancouver

Venderbos LDF, Remmers S, Deschamps A, Dowling J, Carl EG, Pereira-Azevedo N, et al. The Europa Uomo Patient Reported Outcome Study 2.0—Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-making. European Urology Focus. 2023;9(6):1024-1036. doi:10.1016/j.euf.2023.05.006

BibTeX
@article{Venderbos2023,
  author = {Venderbos, Lionne D F and Remmers, Sebastiaan and Deschamps, André and Dowling, John and Carl, Ernst-Günter and Pereira-Azevedo, Nuno and Roobol, Monique J},
  title = {The Europa Uomo Patient Reported Outcome Study 2.0—Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-making},
  journal = {European Urology Focus},
  year = {2023},
  volume = {9},
  number = {6},
  pages = {1024--1036},
  doi = {10.1016/j.euf.2023.05.006}
}
Kostenlos starten →